Aromasin 25
$50.00
Iron Ascension Aromasin 25 (Exemestane) is a potent, steroidal irreversible aromatase inhibitor engineered to eliminate estrogenic side effects and prevent rebound estrogen spikes. Acting as a “suicide inhibitor,” it permanently inactivates the aromatase enzyme, guaranteeing superior estrogen suppression, enhanced fluid clearance, and optimized free testosterone levels.
Guaranteed safe checkout
Description
Description
Iron Ascension Aromasin 25
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | Exemestane |
| Concentration | 25 mg per tablet |
| Total Quantity | 60 tablets |
| Delivery System | Oral administration |
| Formulation Standard | Pharmaceutical grade (manufacturer claim; verification required) |
| Batch Testing | High-Performance Liquid Chromatography (HPLC) |
Key Performance Features
- Irreversible Aromatase Inhibition: Exemestane is a steroidal aromatase inhibitor that irreversibly inactivates aromatase enzymes. However, this does not permanently prevent estrogen production or guarantee protection against post-treatment estrogen rebound, as the body can produce new aromatase enzymes.
- Estrogen Reduction: Exemestane reduces estrogen synthesis by inhibiting aromatase activity. The degree of estrogen suppression varies between individuals; fixed reduction percentages and guaranteed changes in physical appearance should not be claimed.
- Hormonal Effects: Changes in estrogen feedback may influence LH and FSH levels in some individuals. Exemestane should not be presented as a guaranteed testosterone booster or a proven method of post-cycle hormonal recovery.
Important Health Considerations: Excessive estrogen suppression may cause joint pain, hot flashes, fatigue, reduced bone mineral density, increased fracture risk, and adverse cholesterol changes. Exemestane has established medical uses, including treatment of certain hormone-sensitive breast cancers, but other uses require careful medical assessment and monitoring.
Quality Control & Lab Verification
The manufacturer reports that each batch undergoes quantitative testing before allocation.
| Quality Control Parameter | Reported Result |
|---|---|
| Compound | Exemestane (oral tablets) |
| Assay Result | 99.6% active compound (reported) |
| Testing Method | HPLC (reported) |
| Verification Status | PASSED (reported) |
Publication note: The 99.6% assay result, HPLC report, pharmaceutical-grade designation, and tablet formulation should be verified against a genuine, batch-specific certificate of analysis. HPLC assay alone does not establish tablet uniformity, dissolution, contaminant absence, or product safety.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.